EcoDrugPlus

Cholinergic Receptor Nicotinic Alpha 7 Subunit

Ensembl ID : ENSCHYG00000010639
Gene Symbol: CHRNA7
1 Cross references
249 Possible Orthologues:

Cholinergic Receptor Nicotinic Beta 2 Subunit

Ensembl ID : ENSCHYG00000008890
Gene Symbol: CHRNB2
1 Cross references
198 Possible Orthologues:

Cholinergic Receptor Nicotinic Beta 4 Subunit

Ensembl ID : ENSCHYG00000013333
Gene Symbol: CHRNB4
1 Cross references
199 Possible Orthologues:

Coagulation Factor Ii Thrombin Receptor

Ensembl ID : ENSCHYG00000006697
Gene Symbol: F2R
1 Cross references
330 Possible Orthologues:

Coagulation Factor Ii, Thrombin

Ensembl ID : ENSCHYG00000001885
Gene Symbol: F2
1 Cross references
86 Possible Orthologues:

Coagulation Factor Iii, Tissue Factor

Ensembl ID : ENSCHYG00000018591
Gene Symbol: F3
1 Cross references
246 Possible Orthologues:

Coagulation Factor Vii

Ensembl ID : ENSCHYG00000017328
Gene Symbol: F7
1 Cross references
203 Possible Orthologues:

Coagulation Factor X

Ensembl ID : ENSCHYG00000017255
Gene Symbol: F10
1 Cross references
239 Possible Orthologues:

Coagulation Factor Xi

Ensembl ID : ENSCHYG00000014058
Gene Symbol: F11
1 Cross references
215 Possible Orthologues:

Coagulation Factor Xii

Ensembl ID : ENSCHYG00000002373
Gene Symbol: F12
1 Cross references
187 Possible Orthologues:

Colony Stimulating Factor 1 Receptor

Ensembl ID : ENSCHYG00000004143
Gene Symbol: CSF1R
1 Cross references
273 Possible Orthologues:

Complement C1s

Ensembl ID : ENSCHYG00000022602
Gene Symbol: C1S
1 Cross references
199 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).